BioAtla© develops novel therapeutics with improved therapeutic index that are safer and more effective for treating cancerLearn more
Conditionally Active Biologics™ (CAB’s)
BioAtla©‘s revolutionary platform for developing conditionally active therapeutics yields antibodies (or other biologics) that can be activated or inactivated under defined physiological conditions.
We are Hiring!
At BioAtla© we recognize that the success of our business depends on the excellence of our people, and are dedicated to recruiting exceptional talent for our team.